ARTICLE
2 November 2016

Injunction Preventing Use Of Mark Not Available Where Use In The US, And Not Canada (Intellectual Property Weekly Abstracts - Week of October 31, 2016)

BL
Borden Ladner Gervais LLP

Contributor

BLG is a leading, national, full-service Canadian law firm focusing on business law, commercial litigation, and intellectual property solutions for our clients. BLG is one of the country’s largest law firms with more than 750 lawyers, intellectual property agents and other professionals in five cities across Canada.
The Court dismissed the Defendant's motion for an interim and/or interlocutory injunction restraining the Plaintiffs, inter alia, from using any trademarks that are confusingly similar to any of HERC Trademarks.
Canada Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

Trademark Decisions

Injunction preventing use of mark not available where use in the US, and not Canada      

HERTZ System, Inc. v. HERC Equipment Rentals, 2016 FC 1085

The Court dismissed the Defendant's motion for an interim and/or interlocutory injunction restraining the Plaintiffs, inter alia, from using any trademarks that are confusingly similar to any of HERC Trademarks. The parties had business dealings for about 15 years. In 2014, the Plaintiff announced its plan to make its equipment rental business a stand-alone business and further announced that this stand-alone business would be known as Herc Rentals.

In dismissing the Defendant's injunction, the Court found the Plaintiff's evidence that it will only use the Herc name in the United States, and not Canada, strongly supported the conclusion that confusion in Canada is unlikely. On this basis, the Court was not persuaded that any urgency existed that would warrant granting this interim injunction, or that the Defendant would suffer irreparable harm if an injunction was not granted.

Supreme Court Updates

On October 31, 2016, the Honourable Mr. Justice Malcolm Rowe was sworn in as a judge of the Supreme Court of Canada.

Amgen Canada Inc., Amgen Inc. v. Apotex Inc., Minister of Health (FC) (Civil) (By Leave) (37124)

The Supreme Court granted the motion to expedite the application for leave to appeal and dismissed the application for leave to appeal from the judgment of the Federal Court of Appeal (2016 FCA 196, our summary provided here).

Industry News

Health Canada has published a Notice - Guidance Document: Patented Medicines (Notice of Compliance) Regulations.

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More